Anti-Xylazine (Clone X0357)

Specificity: Anti-Xylazine (Clone X0357) is specific for both xylazine and 4-hydroxy xylazine. Background: Xylazine is a potent alpha-2 adrenergic agonist that was initially developed as a veterinary sedative and analgesic medication. Xylazine was not approved for human use and has been increasingly found in samples of illicit drugs like fentanyl. The increase in the detection of xylazine mixed with fentanyl has corresponded with an increase in overdose deaths. In 2023, fentanyl mixed with xylazine was declared an emerging threat by the White House?s Office of National Drug Control Policy.

Product Specifications

Target Antigen

Xylazine

Clonality

Monoclonal

Clone

X0357

Applications

ELISA

Purification

Purity: >=90% Preparation: This monoclonal antibody is purified by protein A chromatography or sequential differential precipitations.

Components

Concentration: >=1.0 mg/mL Formulation: Formulated in 0.01 M phosphate buffered saline, pH 7.2 and contains 0.1% sodium azide. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.